Parent-Infant Interaction for Parenting Intervention
(BIGMIPH Trial)
Trial Summary
What is the purpose of this trial?
Early life experiences, such as those associated with stable attachment, supportive relationships, and nurturing environments, have profound effects on lifelong physical and mental health. However, children have very different levels of access to such experiences, depending on their family characteristics and associated risk and resilience factors. Low-cost interventions aimed at improving infant environments offer a promising avenue for reducing inequality in early experiences because they require minimal effort to implement. Previous work from the Music lab showed the promise of infant-directed vocalizations, especially music, for enriching parent-infant interaction. Such behaviors are cross-culturally universal, appear regularly in the context of infant care, and have robust effects on infant psychophysiology. In recently completed pilot work, it was found that a brief smartphone-based music intervention achieved high adherence and low attrition; led parents to increase their use of music in soothing their fussy infants; and improved infant mood, as reported via ecological momentary assessment (EMA). Together, these findings show the potential for enriched parent-infant interaction, particularly via infant-directed singing, to improve infant and parent health. Here, a Phase II randomized trial is proposed to explore such effects. Parent/infant dyads (N = 192, infant starting ages 0 to 4 months) will be randomly assigned to one of four conditions: (1) music with enrichment, where parents receive a smartphone-based intervention to learn to sing interactively with their infants, via the early childhood music program Music Together; (2) music with limited enrichment, where parents receive music recordings to listen to with their infants, but are not provided with enrichment activities; (3) enrichment with limited music, where parents receive books to read interactively with their infants, but are not provided with music activities; or (4) a no-treatment control. Throughout the 8-month study, a text-message-based EMA and a survey battery will be used to measure key health outcomes for both infants (distress and recovery, sleep quality, and mood) and parents (mood, mental health status, and parenting efficacy); potential moderators of such effects (demographics, family contextual factors, parent/infant attachment, and infant temperament); as well as parents' degree of engagement in the interventions. Effects will be analyzed both across the intervention groups and relative to the no-treatment control to determine the relative effects of each intervention. The results of this work will determine the effects of low-cost, low-effort early enrichment interventions on basic, everyday health outcomes for infants and parents, test the feasibility of app-based interventions and data collection tools (including in socio-economically disadvantaged families), and provide rich data on the daily lives (including mood, temperament, and sleep variables) of families with young infants. The findings will have particular relevance for underprivileged families and first-time parents, and will set the stage for larger-scale studies of early parent-infant enrichment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on parent-infant interactions and does not mention medication requirements.
What data supports the effectiveness of the treatment Enriched Parent-Infant Interaction?
Research on similar treatments like Parent-Child Interaction Therapy (PCIT) shows positive effects on improving parent and child behaviors, especially when parents receive responsive coaching. Additionally, a home-based adaptation of PCIT for at-risk infants showed significant improvements in parent-infant interactions and infant behavior problems.12345
Is Parent-Infant Interaction Therapy safe for humans?
Parent-Infant Interaction Therapy, also known as Parent-Child Interaction Therapy (PCIT), has been widely studied and is considered safe for humans. It is a well-established program used to improve parent-child relationships and reduce children's disruptive behaviors, with no significant safety concerns reported in the research.678910
How does the Enriched Parent-Infant Interaction treatment differ from other treatments for parent-infant interaction issues?
The Enriched Parent-Infant Interaction treatment is unique because it focuses on enhancing the quality of interactions between parents and infants, emphasizing warmth, sensitivity, and support for learning and autonomy. Unlike standard care, this treatment involves structured, home-based interventions that have shown to improve infant compliance and reduce behavior problems, particularly in high-risk families.611121314
Research Team
Samuel Mehr
Principal Investigator
Yale University
Eligibility Criteria
This trial is for parent-infant pairs, with infants aged 0 to 4 months. It's especially relevant for first-time parents and underprivileged families. Participants should be willing to engage in activities like singing, music listening, or book reading with their infant and use an app for intervention guidance.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Parents and infants participate in one of four conditions: music with enrichment, music with limited enrichment, enrichment with limited music, or no-treatment control. The intervention includes smartphone-based music programs, music playlists, or book reading activities.
Post-intervention Assessment
Assessment of primary and secondary outcomes such as parenting efficacy, infant mood, and sleep quality using various scales and ecological momentary assessment.
Follow-up
Participants are monitored for long-term effects on health outcomes for both infants and parents.
Treatment Details
Interventions
- Enriched Parent-Infant Interaction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator